Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37

Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Douglas A Treco

6 Aug 2025

Director

Buy

20,000

$57.03

$1.14M

Simeon George

16 Jul 2025

Director

Buy indirect

960,983

$52.03

$50.00M

Simeon George

16 Jul 2025

Director

Buy indirect

22,319

$52.03

$1.16M

Simeon George

16 Jul 2025

Director

Buy indirect

6,510

$52.03

$338.72K

Naimish Patel

3 Apr 2025

Chief Medical Officer

Buy

1,508

$32.96

$49.70K

John Greene

26 Feb 2025

Director

Buy

7,000

$44.85

$313.95K

Showing 250 of 546 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 439

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 6

Sales on a Rule 10b5-1 plan 11

Sales straight out of an exercise 196

Sales at will 315

Transactions with no price 0

Shares from compensation/vesting 20,354,169

Sales filed before the plan box existed 276

History held since 20 Oct 2016